340B Program Update / by Joe Furia

Debbie Johnston, Senior Vice President of Policy Development 

This week the Senate Health, Education, Labor and Pensions Committee held another series of hearings examining the 340B drug savings program. During the hearing a number of senators spoke about repeated delays in implementing a final rule on 340B drug ceiling prices and civil monetary penalties for manufacturers. The rulemaking on this issue began seven years ago, and last week HRSA proposed delaying the effective date to July 1, 2019.